• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核苷酸切除修复(NER)途径基因ERCC1和XPD的多态性与食管腺癌风险相关。

Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk.

作者信息

Tse Darren, Zhai Rihong, Zhou Wei, Heist Rebecca S, Asomaning Kofi, Su Li, Lynch Thomas J, Wain John C, Christiani David C, Liu Geoffrey

机构信息

Department of Applied Molecular Oncology, Ontario Cancer Institute, Princess Margaret Hospital, Toronto, ON, Canada.

出版信息

Cancer Causes Control. 2008 Dec;19(10):1077-83. doi: 10.1007/s10552-008-9171-4. Epub 2008 May 14.

DOI:10.1007/s10552-008-9171-4
PMID:18478337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3106102/
Abstract

PURPOSE

Functional variation in DNA repair capacity through single nucleotide polymorphisms (SNPs) of key repair genes is associated with a higher risk of developing various types of cancer. Studies have focused on the nucleotide excision repair (NER) and base excision repair (BER) pathways. We investigated whether variant alleles in seven SNPs within these pathways increased the risk of esophageal adenocarcinoma.

METHODS

DNA was extracted from prospectively collected blood specimens. The samples were genotyped for SNPs in NER genes (XPD Lys751Gln, XPD Asp312Asn, ERCC1 8092C/A, and ERCC1 118C/T), and BER genes (XRCC1 Arg399Gln, APE1 Asp148Glu, and hOGG1 Ser326Cys). The presence of variant alleles was correlated with risk of esophageal adenocarcinoma both individually and jointly.

RESULTS

Variant alleles in NER SNPs XPD Lys751Gln (AOR = 1.50, 95% CI 1.1-2.0), ERCC1 8092 C/A (AOR = 1.44, 95% CI 1.1-1.9), and ERCC1 118C/T (AOR = 1.42, 95% CI 1.0-1.9) were individually associated with esophageal adenocarcinoma risk. An increasing number of variant alleles in NER SNPs showed a significant trend with esophageal adenocarcinoma risk (p = 0.007).

CONCLUSIONS

The presence of variant alleles in NER genes increases risk of esophageal adenocarcinoma. There is evidence of an additive role for SNPs along a common DNA repair pathway. Future larger studies of esophageal adenocarcinoma etiology should evaluate entire biological pathways.

摘要

目的

关键修复基因的单核苷酸多态性(SNP)导致DNA修复能力的功能变异与多种癌症的发生风险增加相关。研究主要集中在核苷酸切除修复(NER)和碱基切除修复(BER)途径。我们调查了这些途径中7个SNP的变异等位基因是否会增加食管腺癌的风险。

方法

从前瞻性收集的血液标本中提取DNA。对样本进行NER基因(XPD Lys751Gln、XPD Asp312Asn、ERCC1 8092C/A和ERCC1 118C/T)和BER基因(XRCC1 Arg399Gln、APE1 Asp148Glu和hOGG1 Ser326Cys)的SNP基因分型。分别及联合分析变异等位基因的存在与食管腺癌风险的相关性。

结果

NER SNP中的变异等位基因XPD Lys751Gln(比值比[AOR]=1.50,95%置信区间[CI]1.1 - 2.0)、ERCC1 8092 C/A(AOR = 1.44,95% CI 1.1 - 1.9)和ERCC1 118C/T(AOR = 1.42,95% CI 1.0 - 1.9)分别与食管腺癌风险相关。NER SNP中变异等位基因数量的增加与食管腺癌风险呈显著趋势(p = 0.007)。

结论

NER基因中变异等位基因的存在会增加食管腺癌的风险。有证据表明,常见DNA修复途径中的SNP具有累加作用。未来关于食管腺癌病因的更大规模研究应评估整个生物学途径。

相似文献

1
Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk.核苷酸切除修复(NER)途径基因ERCC1和XPD的多态性与食管腺癌风险相关。
Cancer Causes Control. 2008 Dec;19(10):1077-83. doi: 10.1007/s10552-008-9171-4. Epub 2008 May 14.
2
XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk.XRCC1和XPD基因多态性与食管腺癌风险
Carcinogenesis. 2007 Jun;28(6):1254-8. doi: 10.1093/carcin/bgm020. Epub 2007 Jan 29.
3
Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes.顺铂药物遗传学、DNA修复多态性与食管癌预后
Pharmacogenet Genomics. 2009 Aug;19(8):613-25. doi: 10.1097/FPC.0b013e32832f3010.
4
Polymorphisms in ERCC1 and ERCC2/XPD genes and carcinogen DNA adducts in human lung.人类肺部中ERCC1和ERCC2/XPD基因的多态性与致癌物DNA加合物
Lung Cancer. 2015 Jul;89(1):8-12. doi: 10.1016/j.lungcan.2015.05.001. Epub 2015 May 11.
5
Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.西班牙北部人群中XPC、XPD、XRCC1和XRCC3 DNA修复基因多态性与肺癌风险
BMC Cancer. 2007 Aug 16;7:162. doi: 10.1186/1471-2407-7-162.
6
Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India.XRCC1基因Arg399Gln和XPD基因Lys751Gln的DNA修复基因多态性在印度肺癌患者中的预后重要性。
J Cancer Res Clin Oncol. 2008 Jun;134(6):645-52. doi: 10.1007/s00432-007-0328-4. Epub 2007 Oct 19.
7
Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk.核苷酸切除修复基因多态性、多环芳烃-DNA加合物与乳腺癌风险。
Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2033-41. doi: 10.1158/1055-9965.EPI-07-0096.
8
Association of BER and NER pathway polymorphism haplotypes and micronucleus frequencies with global DNA methylation in benzene-exposed workers of China: Effects of DNA repair genes polymorphisms on genetic damage.中国苯暴露工人中碱基切除修复(BER)和核苷酸切除修复(NER)途径多态性单倍型及微核频率与全基因组DNA甲基化的关联:DNA修复基因多态性对遗传损伤的影响
Mutat Res Genet Toxicol Environ Mutagen. 2019 Mar;839:13-20. doi: 10.1016/j.mrgentox.2019.01.006. Epub 2019 Jan 17.
9
Genetic polymorphisms in DNA repair genes OGG1, APE1, XRCC1, and XPD and the risk of age-related cataract.DNA 修复基因 OGG1、APE1、XRCC1 和 XPD 的遗传多态性与年龄相关性白内障的风险。
Ophthalmology. 2012 May;119(5):900-6. doi: 10.1016/j.ophtha.2011.11.004. Epub 2012 Feb 4.
10
Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.DNA修复基因变异的特定组合与非小细胞肺癌风险增加
Carcinogenesis. 2004 Dec;25(12):2433-41. doi: 10.1093/carcin/bgh264. Epub 2004 Aug 27.

引用本文的文献

1
Relationship between , , , and Polymorphisms and the Susceptibility to Head and Neck Carcinoma: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis.基因多态性与头颈部癌易感性的关系:系统评价、荟萃分析和试验序贯分析。
Medicina (Kaunas). 2024 Mar 14;60(3):478. doi: 10.3390/medicina60030478.
2
Association between polymorphisms of the DNA repair genes RAD51 and OGG1 and risk of cardiovascular disease.DNA 修复基因 RAD51 和 OGG1 多态性与心血管疾病风险的关联。
Mol Med Rep. 2024 Mar;29(3). doi: 10.3892/mmr.2024.13177. Epub 2024 Feb 9.
3
Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma.软组织肉瘤中核苷酸切除修复(NER)途径的改变。
Int J Mol Sci. 2022 Jul 28;23(15):8360. doi: 10.3390/ijms23158360.
4
Distribution and susceptibility of ERCC1/XPF gene polymorphisms in Han and Uygur women with breast cancer in Xinjiang, China.中国新疆地区汉族和维吾尔族乳腺癌患者 ERCC1/XPF 基因多态性的分布及其易感性。
Cancer Med. 2020 Dec;9(24):9571-9580. doi: 10.1002/cam4.3547. Epub 2020 Oct 16.
5
Comprehensive analysis of the correlation between base-excision repair gene SNPs and esophageal squamous cell carcinoma risk in a Chinese Han population.中国汉族人群中碱基切除修复基因单核苷酸多态性与食管鳞状细胞癌风险相关性的综合分析。
Mol Clin Oncol. 2020 Aug;13(2):228-236. doi: 10.3892/mco.2020.2066. Epub 2020 Jun 9.
6
Association between single nucleotide polymorphism of DNA repair genes and endometrial cancer: a case-control study.DNA修复基因单核苷酸多态性与子宫内膜癌的关联:一项病例对照研究。
Int J Clin Exp Pathol. 2018 Mar 1;11(3):1732-1738. eCollection 2018.
7
The hOGG1 Ser326Cys polymorphism and esophageal cancer risk: a meta-analysis of 1,875 cancer cases and 3,041 controls.人8-氧鸟嘌呤DNA糖基化酶1(hOGG1)丝氨酸326位半胱氨酸多态性与食管癌风险:对1875例癌症病例和3041例对照的荟萃分析
Ann Transl Med. 2019 Sep;7(18):438. doi: 10.21037/atm.2019.08.121.
8
From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.从遗传学到信号通路:食管腺癌的分子发病机制。
Biochim Biophys Acta Rev Cancer. 2019 Aug;1872(1):37-48. doi: 10.1016/j.bbcan.2019.05.003. Epub 2019 May 30.
9
ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma.ESCC ATLAS:食管鳞状细胞癌生物标志物的全人群综合纲要。
Sci Rep. 2018 Aug 24;8(1):12715. doi: 10.1038/s41598-018-30579-3.
10
gene polymorphisms and risk of neuroblastoma in Chinese children: a two-center case-control study.中国儿童基因多态性与神经母细胞瘤风险:一项两中心病例对照研究
J Cancer. 2018 Jul 1;9(15):2751-2756. doi: 10.7150/jca.25973. eCollection 2018.

本文引用的文献

1
XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk.XRCC1和XPD基因多态性与食管腺癌风险
Carcinogenesis. 2007 Jun;28(6):1254-8. doi: 10.1093/carcin/bgm020. Epub 2007 Jan 29.
2
Are squamous and adenocarcinomas of the esophagus the same disease?食管鳞状细胞癌和腺癌是同一种疾病吗?
Semin Radiat Oncol. 2007 Jan;17(1):38-44. doi: 10.1016/j.semradonc.2006.09.007.
3
Epidemiology and pathogenesis of esophageal cancer.食管癌的流行病学与发病机制
Semin Radiat Oncol. 2007 Jan;17(1):2-9. doi: 10.1016/j.semradonc.2006.09.003.
4
Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.DNA修复基因XPC、XPD和XPG的多态性与皮肤黑色素瘤风险:一项病例对照分析。
Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2526-32. doi: 10.1158/1055-9965.EPI-06-0672.
5
Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer.患乳腺癌的姐妹中核苷酸切除修复基因多态性与DNA修复能力表型
Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1614-9. doi: 10.1158/1055-9965.EPI-06-0218.
6
Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population.转录因子IIH复合物的两种解旋酶ERCC2/XPD和ERCC3/XPB中的多态性与肺癌风险:一项中国人群的病例对照分析。
Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1336-40. doi: 10.1158/1055-9965.EPI-06-0194.
7
The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden.XPD 751 Gln等位基因与食管腺癌风险增加相关:瑞典一项基于人群的病例对照研究。
Carcinogenesis. 2006 Sep;27(9):1835-41. doi: 10.1093/carcin/bgl017. Epub 2006 Mar 29.
8
ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy.ERCC1基因多态性作为接受铂类化疗的晚期结直肠癌患者临床结局的预测指标。
Clin Adv Hematol Oncol. 2003 Mar;1(3):162-6.
9
ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer.ERCC1基因第118位密码子多态性是晚期结直肠癌患者对奥沙利铂/5-氟尿嘧啶联合化疗肿瘤反应的预测因素。
Clin Cancer Res. 2005 Sep 1;11(17):6212-7. doi: 10.1158/1078-0432.CCR-04-2216.
10
Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk.特定DNA修复基因的遗传多态性、雌激素和孕激素受体状态与乳腺癌风险
Clin Cancer Res. 2005 Jun 15;11(12):4620-6. doi: 10.1158/1078-0432.CCR-04-2534.